Immunome Inc is a biotechnology business based in the US. Immunome Inc shares (IMNM) are listed on the NASDAQ and all prices are listed in US Dollars. Immunome Inc employs 39 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Immunome Inc stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IMNM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Immunome Inc stock price (NASDAQ: IMNM)Use our graph to track the performance of IMNM stocks over time.
Immunome Inc shares at a glance
|Latest market close||$5.36|
|52-week range||$2.09 - $9.30|
|50-day moving average||$3.96|
|200-day moving average||$4.13|
|Wall St. target price||$8.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.73|
Buy Immunome Inc stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Immunome Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Immunome Inc price performance over time
|1 week (2023-02-01)||1.81%|
|1 month (2023-01-04)||N/A|
|3 months (2022-11-07)||14.18%|
|6 months (2022-08-08)||5.62%|
|1 year (2022-02-08)||-33.56%|
|2 years (2021-02-08)||-74.38%|
|3 years (2020-02-04)||N/A|
|5 years (2018-02-04)||N/A|
Immunome Inc financials
|Gross profit TTM||$0|
|Return on assets TTM||-49.62%|
|Return on equity TTM||-94.92%|
|Market capitalisation||$64.2 million|
TTM: trailing 12 months
Immunome Inc share dividends
We're not expecting Immunome Inc to pay a dividend over the next 12 months.
Immunome Inc share price volatility
Over the last 12 months, Immunome Inc's shares have ranged in value from as little as $2.09 up to $9.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immunome Inc's is 0.8334. This would suggest that Immunome Inc's shares are less volatile than average (for this exchange).
To put Immunome Inc's beta into context you can compare it against those of similar companies.
- EXACT Sciences Corporation (EXAS.US): 1.3331
- Blueprint Medicines (BPMC.US): 0.632
- Kura Oncology (KURA.US): 0.8322
Immunome Inc overview
Immunome, Inc. , a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania. .
Immunome Inc in the news
Is Immunome (NASDAQ:IMNM) In A Good Position To Deliver On Growth Plans?
Frequently asked questionsWhat percentage of Immunome Inc is owned by insiders or institutions?
Currently 18.812% of Immunome Inc shares are held by insiders and 19.745% by institutions. How many people work for Immunome Inc?
Latest data suggests 39 work at Immunome Inc. When does the fiscal year end for Immunome Inc?
Immunome Inc's fiscal year ends in December. Where is Immunome Inc based?
Immunome Inc's address is: 665 Stockton Drive, Exton, PA, United States, 19341 What is Immunome Inc's ISIN number?
Immunome Inc's international securities identification number is: US45257U1088
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert